Black Friday: 20% off all orders with code BLACK20.

Peptide Pens

Tesamorelin 10mg Pen

$120.00

Tesamorelin 3 mL Pen

The Science, Simplified: Tesamorelin is a synthetic 44-amino acid analog of growth hormone-releasing hormone (GHRH) featuring an N-terminal trans-3-hexenoyl modification.

Product Specifications – Tesamorelin 10 mg 3 mL Pen

  • Total Tesamorelin: 10 mg
  • Volume: 3 mL pre-filled pen
  • Clicks in the pen: 300
  • Volume per click: 0.01 mL
  • Dial range: 1–60 clicks per dispensing (0.01–0.60 mL)
  • Peptide per click: ≈33.3 mcg Tesamorelin
  • Concentration: ≈3.33 mg/mL
  • Purity: Research-grade, third-party tested (COA available)
  • Format: Ready-to-use multi-dose pre-filled pen

Key Research Focus: GHRH receptor activation and growth hormone release research.

Physical Form & Solubility:

  • Appearance: Clear to slightly opalescent liquid
  • Solubility: Already in aqueous solution (acetate salt form for optimal solubility and stability). Highly soluble; no reconstitution required.

Pen Format Details: The 3 mL pre-filled pen is a sterile, multi-dose delivery system designed for precise, consistent dispensing of the research compound. It features a sealed cartridge, dial-a-dose mechanism for accurate volume control, and a fine-gauge needle interface. The pen is ready for immediate laboratory use with no mixing or transfer steps required. Each pen is labeled with total peptide content and lot-specific COA reference.

Stability & Handling Notes:

  • Refrigerated at 2–8°C (36–46°F). Practical shelf life is 4–6 weeks when protected from light and handled with aseptic technique.
  • Do not freeze. Avoid prolonged room-temperature exposure.
  • Discard after 6 weeks or if the solution becomes cloudy, discolored, or shows particulate matter.
  • Protect from light and moisture at all times.

Tesamorelin Research Studies

Selected English-language peer-reviewed references for laboratory research context. Links open publisher or PubMed/PMC records.

Read the Tesamorelin research overview

  1. Metabolic effects of a growth hormone-releasing factor in obese subjects with reduced growth hormone secretion: a randomized controlled trialPubMed 23015655
  2. Effects of a growth hormone-releasing hormone analog on endogenous GH pulsatility and insulin sensitivity in healthy menPubMed 20943777
  3. The effects of tesamorelin on phosphocreatine recovery in obese subjects with reduced GHPubMed 24178787
  4. Relationship of adiponectin to endogenous GH pulse secretion parameters in response to stimulation with a growth hormone releasing factorPubMed 21531600
  5. Non-clinical pharmacology and safety evaluation of TH9507, a human growth hormone-releasing factor analoguePubMed 17214611
Tesamorelin amino acid chain
Tesamorelin — amino acid chain (N→C)